MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1808.38%
Quick Ratio
1808.38%
Cash Ratio
228.76%
Debt to Asset Ratio
6.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Right-of-use assets
    • Less accumulated depreciation
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
54,124
45,214
75,289
223,125
Marketable securities
364,457
394,763
298,416
168,548
Prepaid expenses and other current assets
9,281
8,559
7,834
5,829
Total current assets
427,862
448,536
381,539
397,502
Total property and equipment
5,476
3,867
3,405
2,614
Less accumulated depreciation
813
734
670
610
Property and equipment, net
4,663
3,133
2,735
2,004
Right-of-use assets
2,759
453
487
520
Other assets
625
579
383
50
Total assets
435,909
452,701
385,144
400,076
Accounts payable
4,356
6,974
2,977
3,768
Accrued expenses
18,673
7,415
12,346
8,140
Operating lease liabilities, current
631
178
172
154
Total current liabilities
23,660
14,567
15,495
12,062
Share repurchase liability
0
1
2
7
Operating lease liabilities, net of current
2,710
377
424
469
Total liabilities
26,370
14,945
15,921
12,538
Common stock, 0.0001 par value, 500,000,000 shares authorized and 47,949,804 issued and outstanding as of june 30, 2026 and 500,000,000 shares authorized and 44,927,953 issued and outstanding as of december 31, 2025
6
6
6
6
Additional paid-in-capital
695,843
686,349
593,407
589,792
Accumulated deficit
-285,088
-247,993
-224,476
-202,414
Accumulated other comprehensive (loss) income
-1,222
-606
286
154
Total stockholders' equity
409,539
437,756
369,223
387,538
Total liabilities and stockholders' equity
435,909
452,701
385,144
400,076
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$364,457K (96.87%↑ Y/Y)Cash and cashequivalents$54,124K (36.05%↑ Y/Y)Prepaid expenses andother current assets$9,281K (116.64%↑ Y/Y)Total property andequipment$5,476K (139.13%↑ Y/Y)Total current assets$427,862K (86.68%↑ Y/Y)Property and equipment,net$4,663K (169.54%↑ Y/Y)Right-of-use assets$2,759K (400.73%↑ Y/Y)Other assets$625K (1150.00%↑ Y/Y)Less accumulateddepreciation$813K (45.18%↑ Y/Y)Total assets$435,909K (88.28%↑ Y/Y)Total liabilities andstockholders' equity$435,909K (88.28%↑ Y/Y)Total stockholders'equity$409,539K (86.80%↑ Y/Y)Total liabilities$26,370K (114.69%↑ Y/Y)Accumulated deficit-$285,088K (-57.68%↓ Y/Y)Accumulated othercomprehensive (loss) income-$1,222K (-11209.09%↓ Y/Y)Additionalpaid-in-capital$695,843K (73.95%↑ Y/Y)Total currentliabilities$23,660K (101.26%↑ Y/Y)Operating leaseliabilities, net of current$2,710K (429.30%↑ Y/Y)Common stock, 0.0001par value,...$6K (20.00%↑ Y/Y)Accrued expenses$18,673K (218.98%↑ Y/Y)Accounts payable$4,356K (-24.43%↓ Y/Y)Operating leaseliabilities, current$631K (357.25%↑ Y/Y)

MBX Biosciences, Inc. (MBX)

MBX Biosciences, Inc. (MBX)